Abstract:Background: Breast fibroadenomas and phyllodes tumors are both fibroepithelial tumors with comparable histological characteristics. However, rapid and precise differential diagnosis is a tough point in clinical pathology. Given the tendency of phyllodes tumors to recur, the difficulty in differential diagnosis with fibroadenomas leads to the difficulty in optimal management for these patients.Method: In this study, we used Raman spectroscopy to differentiate phyllodes tumors from breast fibroadenomas based on the biochemical and metabolic composition and develop a classification model. The model was vali-dated by 5-fold cross-validation in the training set and tested in an independent test set. The potential metabolic differences between the two types of tumors observed in Raman spectroscopy were confirmed by targeted metabolomic analysis using liquid chromatography-tandem mass spectrometry (LC-MS/MS).Results: A total of 204 patients with formalin-fixed paraffin-embedded (FFPE) tissue samples, including 100 fibroadenomas and 104 phyllodes tumors were recruited from April 2014 to August 2021. All patients were randomly divided into the training cohort (n = 153) and the test cohort (n = 51). The Raman classification model could differentiate phyllodes tumor versus fibroadenoma with cross-validation accuracy, sensitivity, precision, and area under curve (AUC) of 85.58 % +/- 1.77 %, 83.82 % +/- 1.01 %, 87.65 % +/- 4.22 %, and 93.18 % +/- 1.98 %, respectively. When tested in the independent test set, it performed well with the test accuracy, sensitivity, specificity, and AUC of 83.50 %, 86.54 %, 80.39 %, and 90.71 %. Furthermore, the AUC was significantly higher for the Raman model than that for ultrasound (P = 0.0017) and frozen section diagnosis (P < 0.0001). When it came to much more difficult diagnosis between fibroadenoma and benign or small-size phyllodes tumor for pathological examination, the Raman model was capable of differentiating with AUC up to 97.45 % and 95.61 %, respectively. On the other hand, targeted metabolomic analysis, based on fresh-frozen tissue samples, confirmed the differential metabolites (including thymine, dihydrothymine, trans-4-hydroxy-l-proline, etc.) identified from Raman spectra between phyllodes tumor and fibroadenoma.Significance and novelty: In this study, we obtained the molecular information map of breast phyllodes tumors provided by Raman spectroscopy for the first time. We identified a novel Raman fingerprint signature with the potential to precisely characterize and distinguish phyllodes tumors from fibroadenoma as a quick and accurate diagnostic tool. Raman spectroscopy is expected to further guide the precise diagnosis and optimal treatment of breast fibroepithelial tumors in the future.

Utilizing Raman Spectral Imaging for distinguishing breast cancer from hyperplasia

Raman Microspectroscopic Investigation and Classification of Breast Cancer Pathological Characteristics

RamanMicrospectral Study and Classification of the Pathological Evolution of Breast Cancer Using Both Principal Component Analysis-Linear Discriminant Analysis and Principal Component Analysis-Support Vector Machine

Assessing pathological features of breast cancer via the multimodal information of multiphoton and Raman imaging

Label-free ex vivo pathological studying on breast cancer tissue by using nonlinear multiphoton and micro-Raman spectral imaging

The Clinical Application of Raman Spectroscopy for Breast Cancer Detection

Studies on Human Breast Cancer Tissues with Raman Microspectroscopy

Microcalcification-Based Tumor Malignancy Evaluation in Fresh Breast Biopsies with Hyperspectral Stimulated Raman Scattering.

Label-free Biomolecular Characterization of Human Breast Cancer Tissue with Stimulated Raman Scattering (SRS) Spectral Imaging (conference Presentation)

High-content stimulated Raman histology of human breast cancer

Raman spectroscopy combined with convolutional neural network for the sub-types classification of breast cancer and critical feature visualization

Resonance Raman spectroscopy for human cancer detection of key molecules with clinical diagnosis

Diagnosing molecular subtypes of breast cancer by means of Raman spectroscopy

Advances in the clinical application of Raman spectroscopy in breast cancer

Serum Raman spectroscopy combined with multiple classification models for rapid diagnosis of breast cancer

A molecular typing method for invasive breast cancer by serum Raman spectroscopy

Raman spectroscopy combined with multivariate statistical algorithms for the simultaneous screening of cervical and breast cancers

Investigation on the Cancer Invasion and Metastasis of Skin Squamous Cell Carcinoma by Raman Spectroscopy

Molecular Fingerprint of Precancerous Lesions in Breast Atypical Hyperplasia.

Precise Diagnosis of Breast Phyllodes Tumors Using Raman Spectroscopy: Biochemical Fingerprint, Tumor Metabolism and Possible Mechanism

Polarized Micro-Raman Spectroscopy and 2D Convolutional Neural Network Applied to Structural Analysis and Discrimination of Breast Cancer